Protagonist Therapeutics Statistics
Total Valuation
PTGX has a market cap or net worth of $5.29 billion. The enterprise value is $4.62 billion.
| Market Cap | 5.29B |
| Enterprise Value | 4.62B |
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PTGX has 62.52 million shares outstanding. The number of shares has increased by 0.97% in one year.
| Current Share Class | 62.52M |
| Shares Outstanding | 62.52M |
| Shares Change (YoY) | +0.97% |
| Shares Change (QoQ) | +0.41% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 84.80% |
| Float | 43.46M |
Valuation Ratios
The trailing PE ratio is 117.48 and the forward PE ratio is 94.59.
| PE Ratio | 117.48 |
| Forward PE | 94.59 |
| PS Ratio | 25.54 |
| Forward PS | 36.16 |
| PB Ratio | 8.19 |
| P/TBV Ratio | 8.20 |
| P/FCF Ratio | 83.02 |
| P/OCF Ratio | 80.79 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 230.72, with an EV/FCF ratio of 72.54.
| EV / Earnings | 100.66 |
| EV / Sales | 22.09 |
| EV / EBITDA | 230.72 |
| EV / EBIT | 243.13 |
| EV / FCF | 72.54 |
Financial Position
The company has a current ratio of 13.05, with a Debt / Equity ratio of 0.02.
| Current Ratio | 13.05 |
| Quick Ratio | 12.94 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.47 |
| Debt / FCF | 0.17 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.80% and return on invested capital (ROIC) is 1.98%.
| Return on Equity (ROE) | 7.80% |
| Return on Assets (ROA) | 1.82% |
| Return on Invested Capital (ROIC) | 1.98% |
| Return on Capital Employed (ROCE) | 2.89% |
| Revenue Per Employee | $1.66M |
| Profits Per Employee | $364,357 |
| Employee Count | 126 |
| Asset Turnover | 0.32 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PTGX has paid $2.16 million in taxes.
| Income Tax | 2.16M |
| Effective Tax Rate | 4.50% |
Stock Price Statistics
The stock price has increased by +98.29% in the last 52 weeks. The beta is 2.20, so PTGX's price volatility has been higher than the market average.
| Beta (5Y) | 2.20 |
| 52-Week Price Change | +98.29% |
| 50-Day Moving Average | 71.05 |
| 200-Day Moving Average | 54.55 |
| Relative Strength Index (RSI) | 65.62 |
| Average Volume (20 Days) | 912,403 |
Short Selling Information
The latest short interest is 5.47 million, so 8.74% of the outstanding shares have been sold short.
| Short Interest | 5.47M |
| Short Previous Month | 6.31M |
| Short % of Shares Out | 8.74% |
| Short % of Float | 12.58% |
| Short Ratio (days to cover) | 3.76 |
Income Statement
In the last 12 months, PTGX had revenue of $209.22 million and earned $45.91 million in profits. Earnings per share was $0.72.
| Revenue | 209.22M |
| Gross Profit | 209.22M |
| Operating Income | 19.01M |
| Pretax Income | 48.07M |
| Net Income | 45.91M |
| EBITDA | 20.03M |
| EBIT | 19.01M |
| Earnings Per Share (EPS) | $0.72 |
Balance Sheet
The company has $576.12 million in cash and $10.75 million in debt, giving a net cash position of $668.07 million or $10.69 per share.
| Cash & Cash Equivalents | 576.12M |
| Total Debt | 10.75M |
| Net Cash | 668.07M |
| Net Cash Per Share | $10.69 |
| Equity (Book Value) | 645.44M |
| Book Value Per Share | 10.34 |
| Working Capital | 541.48M |
Cash Flow
In the last 12 months, operating cash flow was $65.47 million and capital expenditures -$1.76 million, giving a free cash flow of $63.71 million.
| Operating Cash Flow | 65.47M |
| Capital Expenditures | -1.76M |
| Free Cash Flow | 63.71M |
| FCF Per Share | $1.02 |
Margins
Gross margin is 100.00%, with operating and profit margins of 9.09% and 21.94%.
| Gross Margin | 100.00% |
| Operating Margin | 9.09% |
| Pretax Margin | 22.98% |
| Profit Margin | 21.94% |
| EBITDA Margin | 9.57% |
| EBIT Margin | 9.09% |
| FCF Margin | 30.45% |
Dividends & Yields
PTGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.97% |
| Shareholder Yield | -0.97% |
| Earnings Yield | 0.87% |
| FCF Yield | 1.20% |
Analyst Forecast
The average price target for PTGX is $86.44, which is 2.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $86.44 |
| Price Target Difference | 2.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 2.27% |
| EPS Growth Forecast (5Y) | 0.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PTGX has an Altman Z-Score of 31.5 and a Piotroski F-Score of 5.
| Altman Z-Score | 31.5 |
| Piotroski F-Score | 5 |